An update on human ehrlichioses

Central African Journal of Medicine

Volumn 46, Issue 10, 2000, Pages 277-282

  Pretorius, A M ^a   Kelly, P J ^b  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; TETRACYCLINE DERIVATIVE;

AFRICA; ARTICLE; CLASSIFICATION; COMMUNICABLE DISEASE; EHRLICHIA; EHRLICHIOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GENOTYPE; HUMAN; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SEROTYPING; WESTERN BLOTTING;

AFRICA; BLOTTING, WESTERN; COMMUNICABLE DISEASES, EMERGING; DNA, BACTERIAL; EHRLICHIA; EHRLICHIOSIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; SEROTYPING; TETRACYCLINES;

EID: 0034305928     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Rikihisa Y. The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev 1991;4:286-308.
2. Rikihisa Y. Ehrlichiae of veterinary importance. In: Raoult D, Brouqui P, editors. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris: Elsevier, 1999: 393-405.
3. McQuiston JH, Paddock CD, Holman RC, Childs J. The human ehrlichioses in the United States. Emerg Infect Dis 1999;5:635-42.
4. Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996;2:18-29.
5. Wilson K. Characterization of novel bacterial pathogens by amplification and sequencing of 16S ribosomal RNA genes. In: Ehrlich GD, Greenberg SJ, editors. PCR-based diagnostics in infectious diseases. Boston: Blackwell Scientific Publications, 1994: 649-63.
6. Sumner JW, Nicholson WL, Massung RF. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol 1997; 35:2087-92.
7. Yu X-J, Crocquet-Valdes P, Cullman LC, Walker DH. Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis. Gene 1997;184:149-54.
8. Paddock CD, Sumner JW, Shore GM, Bartley DC, Elie RC, McQuade JG, et al. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 1997;35:2496-502.
9. Kelly PJ. Canine ehrlichioses: an update. J S Afr Vet Assoc 2000;71:77-86.
10. Misao T, Kobayashi Y. Studies on infectious mononucleosis. 1. Isolation of etiologic agents from blood, bone marrow, and lymph node of a patient with infectious mononucleosis by using mice. Tokyo Iji Shinshi 1954;71:683-6.
11. Fukuda T, Kitao T, Keida Y. Studies on the causative agent of "Hyuganetsu" disease. 1. Isolation of the agent and its inoculation trial in human beings. Med Biol 1954;32:200-9.
12. Ristic M. Current strategies in research on ehrlichiosis. In: Williams JC, Kakoma I, editors. Ehrlichiosis: a vector-borne disease of animals and humans. Boston: Kluwer Academic Publishers, 1990: 136-53.
13. Fukuda T, Sasahara T, Kitao T. Studies on the causative agent of Hyuganetsu disease. XI. Characteristics of rickettsia-like organism isolated from metacercaria of Stellantchasmus falcatus parasitic in grey mullet. J Jpn Assoc Infect Dis 1973;47:474-82.
14. Maeda K, Markowitz N, Hawley RC, Ristic, M, Cox D, McDade JE, et al. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl Med J 1987;316:853-6.
15. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991;29:2838-42.
16. Dawson JE, Biggie KL, Warner CK, Cookson K, Jenkins S, Levine JF, et al. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of ehrlichiosis, in dogs from southeast Virginia. Am J Vet Res 1996;57:1175-79.
17. Morais JD, Dawson JE, Greene C, Filipe AR, Galhardas LC, Bacellar F. First European case of ehrlichiosis. Lancet 1991;338:633-4.
18. Guerrero A, Fishbein DB, Mesa E, Escudero R. [Human infection by Ehrlichia canis in Spain? (letter)]. Infeccion humana por Ehrlichia canis en Espana? Med Clin (Barc) 1991;96:236-7.
19. Davies G. Bovine petechial fever (Ondiri disease). Vet Microbiol 1993;34:103-21.
20. Anderson BE, Sims KG, Olson JG, Childs JE, Piesman JF, Happ CM, et al. Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg 1993;49:239-44.
21. Dawson JE, Stallknecht DE, Howerth EW, Warner C, Biggie K, Davidson WR, et al. Susceptibility of white-tailed deer (Odocoileus virginianus)to infection with Ehrlichia chaffeensis, the etiological agent of human ehrlichiosis. J Clin Microbiol 1994;32:2725-8.
22. Ewing SA, Dawson JE, Kocan AA, Barker RW, Warner CK, Panciera RJ, et al. Experimental transmission of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) among white-tailed deer by Amblyomma americanum (Acari:Ixodidae). J Med Entomol 1995;32:368-74.
23. Lockhart JM, Davidson WR, Stallknecht, DE, Dawson JE, Howerth EW. Isolation of Ehrlichia chaffeensis from wild white-tailed deer (Odocoileus virginianus) confirms their role as natural reservoir hosts. J Clin Microbiol 1997;35:1681-6.
24. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.
25. Eng TR, Harkess JR, Fishbein DB, Dawson JE, Green CN, Redus MA, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States. JAMA 1988;264:2251-8.
26. Patel RG, Byrd MA. Near fatal acute respiratory distress syndrome in apatient with human ehrlichiosis. South Med J 1999;92:333-5.
27. Weaver RAR, Virella G, Weaver A. Ehrlichiosis with severe pulmonary manifestations despite early treatment. South Med J 1999;92:336-9.
28. Whitt SP, Everett ED, Roland W, Dolan S. Ehrlichia chaffeensis - associated cardiomyopathy in a patient with AIDS. Clin Infect Dis 1999;28:140.
29. Bakken JS, Dumler JS, Chen S-M, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest. A new species emerging? JAMA 1994;272:212-8.
30. Chen S-M, Dumler JS, Bakken JS, Walker DH. Identification of a granulotropic Ehrlichia species as the etiological agent of human disease. J Clin Microbiol 1994;32:589-95.
31. Lotric-Furlan S, Petrovec M, Zupanc TA, Nicholson WL, Sumner JW, Childs JE. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 1998;27:424-8.
32. Dumler JS, Bakken JS. Human ehrlichioses: newly recognized infections transmitted by ticks. Ann Rev Med 1998;49:201-13.
33. Petrovec M, Sumner JW, Nicholson WL, Childs JE, Strle F, Barlic J, et al. Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol 1999;37:209-10.
34. Pusterla N, Leutenegger CM, Chae J-S, Lutz H, Kimsey RB, Dumler SJ, et al. Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks. J Clin Microbiol 1999;37:4042-4.
35. Ogden NH, Bown K, Horrocks BK, Woldehiwet Z, Bennett M. Granulocytic Ehrlichia infection in ixodid ticks and mammals in woodlands and uplands of the UK. Med Vet Entomol 1998;12:423-9.
36. Ewing SA, Dawson JE, Panciera RJ, Matthew JS, Pratt KW, Katavolos P, et al. Dogs infected with human granulocytotropic Ehrlichia spp. (Rickettsiales: Ehrlichieae). J Med Entomol 1997;34:710-8.
37. Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, Kurtti TJ, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-15.
38. Weber R, Pusterla N, Loy M, Lutz H. Fever, leucopenia, and thrombocytopenia in a patient with acute Lyme borreliosis were due to human granulocytic ehrlichiosis [letter; comment]. Clin Infect Dis 1998;26:253-4.
39. Petrovec M, Lotric-Furlan S, Zupanc TA, Strle F, Brouqui P, Roux V, et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997;35:1556-9.
40. Dumler JS. Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological factors. Clin Infect Dis 1997;25Suppl. 1:S43-7. Review.
41. Pretorius A-M, Kelly PJ. Serological survey for antibodies reactive with Ehrlichia canis and E. chaffeensis in dogs from the Bloemfontein area of South Africa. J S Afr Vet Assoc 1998; 64:126-8.
42. Perez M, Rikisha Y, Wen B. Ehrlichia caws-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol 1996;34:2133-9.
43. Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikihisa Y, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999;341:148-55.
44. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199-205.
45. Holland CJ, Ristic M, Huxsoll DL, Cole AI, Rapmund G. Adaptation of Ehrlichia sennetsu to canine blood monocytes: preliminary structural and serological studies with cell culture-derived Ehrlichia sennetsu. Infect Immun 1985;48:366-71.
46. Hoillien CA, Ristic M, Huxsoll G, Rapmund G, Tachibana N. Rickettsia sennetsu in human blood monocyte cultures: similarities to the growth cycle of Ehrlichia canis. Infect Immun 1982;35:314-9.
47. Kelly DJ, Lee M, Lewis GE. A light and electron microscopic examination of Ehrlichia sennetsu in cultured human endothelial cell. JPN J Med Sci Biol 1985;38:155-68.
48. Cole AI, Ristic M, Lewis GE, Rapmund G. Continuous propagation of Ehrlichia sennetsu in murine macrophage cell culture. Am J Trop Med Hyg 1985;34:774-80.
49. Rikihisa Y, Pretzman CI, Johnson GC, Reed SM, Yamamoto S, Anddrews F. Clinical, histopathological, and immunological responses of ponies to Ehrlichia sennetsu, and subsequent Ehrlichia risticii challenge. Infect Immun 1988;56:2960-6.
50. Dawson JE, Anderson BE, Fishbein DB, Sanchez JL, Goldsmith CS, Wilson KH, et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991;29:2741-5.
51. Brouqui P, Birg ML, Raoult D. Cytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines. Infect Immun 1994;62:405-11.
52. Everett, CD, Evans KA, Henry RB, McDonald G Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994;120:730-5.
53. Dumler JS, Bakken JS. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J Infect Dis 1996;173: 1027-30.
54. Harrus S, Waner T, Aizenberg I, Foley JE, Poland AM, Bark H. Amplification of ehrlichial DNA from dogs 34 months after infection with E. canis. J Clin Microbiol 1998;36:73-6.
55. Massung RF, Slater K, Owens JH, Nicholson WL, Mather TN, Solberg VB, et al. Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol 1998;36:1090-5.
56. Comer JA, Nicholson WL, Olson JG, Childs JE. Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol 1999;37:558-64.
57. Nicholson WL, Comer JA, Sumner JW, Gingrich-Baker C, Coughlin RT, et al. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997;35:1510-6.
58. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. M M W R 1997;46:46-7.
59. Brouqui P, Lecam C, Olson J, Raoult D. Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis. Clin Diag Lab Immunol 1994;1:645-9.
60. Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R, Madigan JE. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic ehrlichia. J Clin Microbiol 1995;33:1098-103.
61. Rikihisa Y, Baoming MJ. In vitro susceptibilities of Ehrlichia risticii to eight antibiotics. Antimicrob Agents Chemother 1988;32:986-91.
62. Brouqui P, Raoult D. In vitro susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob Agents Chemother 1992;36:2799-803.
63. Dumler JS, Brouqui P, Aronson J, Taylor JP, Walker DH. Identification of ehrlichia in human tissue. N Engl J Med 1991;325:1109-10.
64. Buitrago MI, Ijdo JW, Rinaudo P, Simon H, Copel J, Gadbaw J, et al. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 1998;27:213-5.
65. Pretorius A-M, Venter TP, van der Ryst E, Kelly PJ. A case report of possible human ehrlichiosis in the Free State Province of South Africa. S Afr Med J 1999;89:961.
66. Uhaa IJ, Maclean JD, Greene CR, Fishbein DB. A case of human ehrlichiosis acquired in Mali: clinical and laboratory findings. Am J Trop Med Hyg 1992;46:161-4.
67. Brouqui P, Le Cam C, Kelly PJ, Laurens R, Tounkara A, Sawadogo S, et al. Serologic evidence for human ehrlichiosis in Africa. Eur J Epidemiol 1994; 10:695-8.
68. Brouqui P, Dumler JS. Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Infect Dis 2000;6:314.